Omega Healthcare Investors Stock Revenue
| 0KBL Stock | 40.80 0.14 0.34% |
Omega Healthcare Investors fundamentals help investors to digest information that contributes to Omega Healthcare's financial success or failures. It also enables traders to predict the movement of Omega Stock. The fundamental analysis module provides a way to measure Omega Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omega Healthcare stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 949.7 M | 997.2 M |
Omega | Revenue |
Omega Healthcare Investors Company Revenue Analysis
Omega Healthcare's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Omega Healthcare Revenue | 949.74 M |
Most of Omega Healthcare's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omega Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Omega
Projected quarterly revenue analysis of Omega Healthcare Inv provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Omega Healthcare match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Omega Healthcare's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Omega Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Omega Healthcare Investors reported 949.74 M of revenue. This is 72.85% lower than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The revenue for all United Kingdom stocks is 89.93% higher than that of the company.
Omega Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omega Healthcare's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omega Healthcare could also be used in its relative valuation, which is a method of valuing Omega Healthcare by comparing valuation metrics of similar companies.Omega Healthcare is currently under evaluation in revenue category among its peers.
Omega Fundamentals
| Return On Equity | 0.0867 | |||
| Return On Asset | 0.039 | |||
| Profit Margin | 0.34 % | |||
| Operating Margin | 0.66 % | |||
| Current Valuation | 15.74 B | |||
| Shares Outstanding | 214.53 M | |||
| Shares Owned By Insiders | 0.28 % | |||
| Shares Owned By Institutions | 73.70 % | |||
| Price To Sales | 8.95 X | |||
| Revenue | 949.74 M | |||
| Gross Profit | 794.08 M | |||
| EBITDA | 810.84 M | |||
| Net Income | 248.8 M | |||
| Total Debt | 5.07 B | |||
| Book Value Per Share | 15.69 X | |||
| Cash Flow From Operations | 617.74 M | |||
| Earnings Per Share | 1.86 X | |||
| Number Of Employees | 57 | |||
| Beta | 0.98 | |||
| Market Capitalization | 905.18 B | |||
| Total Asset | 9.12 B | |||
| Retained Earnings | (3.15 B) | |||
| Net Asset | 9.12 B | |||
| Last Dividend Paid | 2.68 |
About Omega Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omega Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omega Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omega Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Omega Stock Analysis
When running Omega Healthcare's price analysis, check to measure Omega Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Healthcare is operating at the current time. Most of Omega Healthcare's value examination focuses on studying past and present price action to predict the probability of Omega Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Healthcare's price. Additionally, you may evaluate how the addition of Omega Healthcare to your portfolios can decrease your overall portfolio volatility.